Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
ID06772831

Cognitive Reappraisal Training Targeting Emotion Circuits As a Therapeutic Intervention in Borderline Patients

Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-12-03

130

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

I

Icahn School of Medicine at Mount Sinai

Lead Sponsor

W

William Marsh Rice University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Borderline Personality Disorder (BPD) is a common and serious psychiatric condition characterized by extreme mood swings and emotional instability, affecting about 2% to 5.9% of people. It poses high risks including suicidality and impaired daily functioning. This research aims to refine and test a focused cognitive reappraisal training method called reappraisal-by-distancing to see if it can improve neural and behavioral responses related to emotional regulation and enhance clinical outcomes in BPD patients. The study compares two behavioral treatments given twice weekly over 6 weeks: one group receives cognitive reappraisal-by-distancing training involving practice with negative emotional pictures guided by a therapist, while the other group practices their usual emotion regulation strategies under therapist guidance. The initial phase tests 2-, 4-, and 6-week treatment durations to identify the optimal dose using brain imaging and clinical ratings. The follow-up phase uses the optimal 6-week dose to confirm results and assess clinical improvements at treatment end and up to 4 months later. Participants attend regular sessions during the treatment period and undergo assessments including fMRI brain scans, clinical rating scales, and questionnaires evaluating emotion regulation, stress, mood, and anxiety at baseline, during treatment, and at follow-ups. The primary outcome is change in brain activity linked to emotional response, while secondary outcomes include changes in borderline symptoms and emotional regulation measures. Safety and clinical progress are monitored throughout the study, which lasts several months including follow-up periods.

CONDITIONS

Brief Title

Cognitive Reappraisal Training for Borderline Personality (BPD)

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 55 years
  • Medically healthy men and women with Borderline Personality Disorder
  • Mentally competent and able to give voluntary written consent
  • Includes participants with comorbid avoidant personality disorder
  • Includes participants with PTSD only if not currently experiencing symptoms
Not Eligible

You will not qualify if you...

  • Diagnosis of Schizotypal Personality Disorder
  • Current Major Depressive Disorder
  • Active PTSD or bipolar I disorder
  • Schizophrenia or schizoaffective disorder
  • Substance use disorder within the past 6 months or IV substance use disorder at any time
  • Organic mental syndromes, head trauma, CNS neurological disease, or seizure disorder
  • Presence of pacemaker, surgical clips, metallic implants, or shrapnel preventing MRI
  • Pregnant women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 6 weeks

Participants receive twice-weekly cognitive reappraisal training sessions or practice customary emotion regulation techniques guided by a therapist.

Twice-weekly visits for 6 weeks

Follow-up

Duration - 4 months

Participants are monitored at 1 month and 4 months after treatment to assess clinical outcomes and emotional regulation improvements.

2 visits (in-person) at 1 month and 4 months post-treatment

Trial Site Locations

Total: 1 location

1

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

Loading map...

Research Team

H

Harold W Koenigsberg, MD

B

Brian B Kang, BA

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Randomised Double-blind Placebo Controlled Investigation o...

Borderline Personality Disorder

Actively Recruiting

1 location

A Precision Medicine Approach to Target Engagement for Emoti...

Emotional Regulation

Actively Recruiting

1 location

A Phase Ib, Multicentre, Randomised, Double Blind, Placebo C...

Borderline Personality Disorder

Actively Recruiting

9 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here